Human leukocyte antigen sensitization after transplant loss: Timing of antibody detection and implications for prevention

Human Immunology

Volumn 72, Issue 5, 2011, Pages 398-401

  Scornik, Juan C ^a   Kriesche, Herwig Ulf Meier ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Graft loss; HLA antibodies; Immunosuppression; Renal transplants; Sensitization

Indexed keywords

HLA ANTIBODY; HLA ANTIGEN;

ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD TRANSFUSION; FEMALE; GRAFT FAILURE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DONOR; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; PRIORITY JOURNAL; RETRANSPLANTATION; RISK FACTOR; SENSITIZATION;

ADOLESCENT; ADULT; ANTIBODY FORMATION; BLOOD TRANSFUSION; FEMALE; GRAFT REJECTION; HLA ANTIGENS; HUMANS; IMMUNIZATION; IMMUNOSUPPRESSIVE AGENTS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEPHRECTOMY; POSTOPERATIVE COMPLICATIONS; TIME FACTORS; WITHHOLDING TREATMENT;

EID: 79954604140     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.02.018     Document Type: Article

References (17)

1. Montgomery R.A., Zachary A.A., Racusen L.C., Leffell M.S., King K.E., Burdick J., et al. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 2000, 70:887-895.
2. Gloor J.M., DeGoey S.R., Pineda A.A., Moore S.B., Prieto M., Nyberg S.L., et al. Overcoming a positive crossmatch in living-donor kidney transplantation. Am J Transplant 2003, 3:1017-1023.
3. Haririan A., Nogueira J., Kukuruga D., Schweitzer E., Hess J., Gurk-Turner C., et al. Positive cross-match living donor kidney transplantation: longer-term outcomes. Am J Transplant 2009, 9:536-542.
4. Kraus E.S., Parekh R.S., Oberai P., Lepley D., Segev D.L., Bagnasco S., et al. Subclinical rejection in stable positive crossmatch kidney transplant patients: incidence and correlations. Am J Transplant 2009, 9:1826-1834.
5. Montgomery R.A., Zachary A.A., Ratner L.E., Segev D.L., Hiller J.M., Houp J., et al. Clinical results from transplanting incompatible live kidney donor/recipient pairs using kidney paired donation. JAMA 2005, 294:1655-1663.
6. Scornik J.C., Schold J.D., Bucci M., Meier-Kriesche H.U. Effects of blood transfusions given after renal transplantation. Transplantation 2009, 87:1381-1386.
7. Scornik J.C., Guerra G., Schold J.D., Srinivas T.R., Dragun D., Meier-Kriesche H.U. Value of posttransplant antibody tests in the evaluation of patients with renal graft dysfunction. Am J Transplant 2007, 7:1808-1814.
8. Mizutani K., Terasaki P., Rosen A., Esquenazi V., Miller J., Shih R.N., et al. Serial ten year follow-up of HLA and MICA antibody production prior to kidney graft failure. Am J Transplant 2005, 5:2265-2272.
9. Scornik J.C., Ireland J., Howard R.J., Pfaff W.W., Fennell R.S. Sensitization by blood transfusions in previously transplanted patients. Transplantation 1983, 35:505-506.
10. Sanfilippo F., Goeken N., Niblack G., Scornik J., Vaughn W.K. The effect of first cadaver renal transplant HLA-A, B match on sensitization levels and re-transplant rates following graft failure. Transplantation 1987, 43:240-244.
11. Meier-Kriesche H.U., Scornik J.C., Susskind B., Rehman S., Schold J.D. A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients. Transplantation 2009, 88:23-29.
12. Scornik J.C., Brunson M.E., Howard R.J., Pfaff W.W. Alloimmunization, memory, and the interpretation of crossmatch results for renal transplantation. Transplantation 1992, 54:389-394.
13. Adeyi O.A., Girnita A.L., Howe J., Marrari M., Awadalla Y., Askar M., et al. Serum analysis after transplant nephrectomy reveals restricted antibody specificity patterns against structurally defined HLA class I mismatches. Transpl Immunol 2005, 14:53-62.
14. Billen E.V.A., Christians M.H.L., Lee J., van den Berg-Loonen E.M. Donor-directed HLA antibodies before and after transplantectomy detected by the Luminex single antigen assay. Transplantation 2009, 87:563-569.
15. Flye M.W., Burton K., Mohanakumar T., Brennan D., Keller C., Goss J.A., et al. Donor-specific transfusions have long-term beneficial effects for human renal allografts. Transplantation 1995, 60:1395-1401.
16. Al-Muzairai I.A., Innes A., Hillis A., Stewart K.N., Bone J.M., Catto G.R., et al. Renal transplantation: cyclosporin A and antibody development after donor-specific transfusion. Kidney Int 1989, 35:1057-1063.
17. Cheigh J.S., Suthanthiran M., Fotino M., Riggio R.R., Schechter N., Stubenbord W.T., et al. Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporine. Transplantation 1991, 51:378-381.